Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BMPR2 mutation is a potential predisposing genetic risk factor for congenital heart disease associated pulmonary vascular disease.

International journal of cardiology - 15 May 2016

Liu Dong, Liu Qian-Qian, Guan Li-Hua, Jiang Xin, Zhou Da-Xin, Beghetti Maurice, Qu Jie-Ming, Jing Zhi-Cheng

Abstract excerpt

BACKGROUND: Pulmonary arterial hypertension (PAH) frequently arises in patients with congenital heart disease (CHD) and can lead to pulmonary vascular disease (PVD). The present study was initiated to distinguish the predisposing effect of bone morphogenetic protein receptor 2 (BMPR2) in CHD by comparing the different mutation features of BMPR2 between CHD patients with or without PVD. METHODS AND RESULTS: 294...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Bone Morphogenetic Protein Receptors, Type II

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Heart Defects, Congenital

Share to Mutation

Share to Risk Factors

Share to Vascular Resistance

Share to Young Adult

Source

Identifiers

PMID: 27002414
DOI: 10.1016/j.ijcard.2016.02.150

Genes

BMPR2
PAH
PVR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BMPR2 mutation is a potential predisposing genetic risk factor for congenital heart disease associated pulmonary vascular disease.PMID 27002414Read ↗

BMPR2 mutations in pulmonary arterial hypertension with congenital heart diseaseSemantic proximity Read ↗

Genetic background of pulmonary (vascular) diseases - how much is written in the codes?Semantic proximity Read ↗

Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis.Semantic proximity Read ↗

Identification of a novel mutation in the BMPR2 gene in a pulmonary arterial hypertension patient using next-generation sequencing.Semantic proximity Read ↗

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation.Semantic proximity Read ↗

The Genetics of Pulmonary Arterial Hypertension in the <i>Post‐BMPR2</i> EraSemantic proximity Read ↗

BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension.Semantic proximity Read ↗

New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis.Semantic proximity Read ↗

The prevalence of pathogenic variants in the BMPR2 gene in patients with idiopathic pulmonary arterial hypertension in the Russian population: sequencing data and meta-analysisSemantic proximity Read ↗

A systematic review of genetic mutations in pulmonary arterial hypertension.Semantic proximity Read ↗

Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort.Semantic proximity Read ↗

Recent advances in pulmonary arterial hypertensionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.